Mitral valve disease

Area of Science:

• Cardiology and cardiovascular research
• Cardiac mechanics and function

Background:

• Cellular contractile dysfunction post-mitral regurgitation is reversible.
• Left ventricular dysfunction can arise from chordal-ventricular disruption.
• Muscle dysfunction is measurable via stress/strain, independent of loading.

Purpose of the Study:

• To explore the reversibility of cellular contractile dysfunction in mitral regurgitation.
• To investigate the mechanisms of left ventricular dysfunction in mitral regurgitation.
• To identify predictors of outcome in mitral regurgitation.

Main Methods:

• Experimental models of mitral regurgitation.
• Measurements of ventricular stress and strain.
• Analysis of clinical outcomes including end-systolic diameter and chordal preservation.

Main Results:

• Contractile dysfunction is potentially reversible.
• Hypertrophy may be insufficient for hemodynamic load, with myofibril lysis observed.
• End-systolic diameter is a key predictor of post-replacement outcomes.
• Heart rate variability shows potential predictive value.

Conclusions:

• Cellular and left ventricular dysfunction in mitral regurgitation have distinct mechanisms and potential for reversibility.
• Clinical outcomes are influenced by factors like end-systolic diameter and potentially chordal integrity.
• Further research into predictive measures and therapeutic strategies is warranted.